15-89652736-C-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198525.3(KIF7):​c.195G>C​(p.Ala65Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.904 in 1,551,594 control chromosomes in the GnomAD database, including 636,685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A65A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.90 ( 62636 hom., cov: 35)
Exomes 𝑓: 0.90 ( 574049 hom. )

Consequence

KIF7
NM_198525.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -6.59

Publications

21 publications found
Variant links:
Genes affected
KIF7 (HGNC:30497): (kinesin family member 7) This gene encodes a cilia-associated protein belonging to the kinesin family. This protein plays a role in the sonic hedgehog (SHH) signaling pathway through the regulation of GLI transcription factors. It functions as a negative regulator of the SHH pathway by preventing inappropriate activation of GLI2 in the absence of ligand, and as a positive regulator by preventing the processing of GLI3 into its repressor form. Mutations in this gene have been associated with various ciliopathies. [provided by RefSeq, Oct 2011]
KIF7 Gene-Disease associations (from GenCC):
  • acrocallosal syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hydrolethalus syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hydrolethalus syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • multiple epiphyseal dysplasia, Al-Gazali type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 15-89652736-C-G is Benign according to our data. Variant chr15-89652736-C-G is described in ClinVar as Benign. ClinVar VariationId is 129408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.952 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF7NM_198525.3 linkc.195G>C p.Ala65Ala synonymous_variant Exon 2 of 19 ENST00000394412.8 NP_940927.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF7ENST00000394412.8 linkc.195G>C p.Ala65Ala synonymous_variant Exon 2 of 19 5 NM_198525.3 ENSP00000377934.3
KIF7ENST00000445906.1 linkn.195G>C non_coding_transcript_exon_variant Exon 2 of 5 1 ENSP00000395906.1
KIF7ENST00000696512.1 linkc.318G>C p.Ala106Ala synonymous_variant Exon 2 of 19 ENSP00000512678.1

Frequencies

GnomAD3 genomes
AF:
0.905
AC:
137730
AN:
152204
Hom.:
62589
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.960
Gnomad AMI
AF:
0.950
Gnomad AMR
AF:
0.797
Gnomad ASJ
AF:
0.838
Gnomad EAS
AF:
0.735
Gnomad SAS
AF:
0.853
Gnomad FIN
AF:
0.888
Gnomad MID
AF:
0.899
Gnomad NFE
AF:
0.918
Gnomad OTH
AF:
0.898
GnomAD2 exomes
AF:
0.863
AC:
133341
AN:
154422
AF XY:
0.867
show subpopulations
Gnomad AFR exome
AF:
0.965
Gnomad AMR exome
AF:
0.736
Gnomad ASJ exome
AF:
0.844
Gnomad EAS exome
AF:
0.739
Gnomad FIN exome
AF:
0.886
Gnomad NFE exome
AF:
0.919
Gnomad OTH exome
AF:
0.869
GnomAD4 exome
AF:
0.904
AC:
1265485
AN:
1399272
Hom.:
574049
Cov.:
68
AF XY:
0.904
AC XY:
623846
AN XY:
690168
show subpopulations
African (AFR)
AF:
0.962
AC:
30410
AN:
31596
American (AMR)
AF:
0.745
AC:
26597
AN:
35694
Ashkenazi Jewish (ASJ)
AF:
0.851
AC:
21416
AN:
25176
East Asian (EAS)
AF:
0.690
AC:
24652
AN:
35726
South Asian (SAS)
AF:
0.876
AC:
69366
AN:
79218
European-Finnish (FIN)
AF:
0.887
AC:
43684
AN:
49252
Middle Eastern (MID)
AF:
0.877
AC:
4995
AN:
5694
European-Non Finnish (NFE)
AF:
0.920
AC:
992227
AN:
1078918
Other (OTH)
AF:
0.899
AC:
52138
AN:
57998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
6171
12342
18512
24683
30854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21112
42224
63336
84448
105560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.905
AC:
137834
AN:
152322
Hom.:
62636
Cov.:
35
AF XY:
0.900
AC XY:
67040
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.960
AC:
39926
AN:
41594
American (AMR)
AF:
0.797
AC:
12196
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.838
AC:
2908
AN:
3470
East Asian (EAS)
AF:
0.735
AC:
3803
AN:
5176
South Asian (SAS)
AF:
0.853
AC:
4111
AN:
4822
European-Finnish (FIN)
AF:
0.888
AC:
9432
AN:
10620
Middle Eastern (MID)
AF:
0.891
AC:
262
AN:
294
European-Non Finnish (NFE)
AF:
0.918
AC:
62440
AN:
68026
Other (OTH)
AF:
0.894
AC:
1890
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
683
1366
2048
2731
3414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.902
Hom.:
6643
Bravo
AF:
0.898
Asia WGS
AF:
0.798
AC:
2776
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Apr 25, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Acrocallosal syndrome Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hydrolethalus syndrome 2 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Multiple epiphyseal dysplasia, Al-Gazali type Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.049
DANN
Benign
0.62
PhyloP100
-6.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8179066; hg19: chr15-90195967; COSMIC: COSV67997612; API